CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-05 | Venker Eric Chief Operating Officer | Sale 10b5-1 | −153,027 | $10.11 | $1.5M | 595,397 |
| 2023-10-04 | Venker Eric Chief Operating Officer | Option exercise 10b5-1 | +153,027 | $3.85 | $589K | 748,424 |
| 2023-10-04 | Venker Eric Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −153,027 | 12,623,184 | ||
| 2023-10-03 | Venker Eric Chief Operating Officer | Option exercise 10b5-1 | +606,221 | $3.85 | $2.3M | 1,201,618 |
| 2023-10-03 | Venker Eric Chief Operating Officer | Sale 10b5-1 | −606,221 | $10.25 | $6.2M | 595,397 |
| 2023-10-03 | Venker Eric Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −606,221 | 12,776,211 | ||
| 2023-10-02 | Venker Eric Chief Operating Officer | Option exercise 10b5-1 | +440,752 | $3.85 | $1.7M | 1,036,149 |
| 2023-10-02 | Venker Eric Chief Operating Officer | Sale 10b5-1 | −440,752 | $10.80 | $4.8M | 595,397 |
| 2023-10-02 | Venker Eric Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −440,752 | 13,382,432 | ||
| 2023-09-29 | Pulik Richard CFO | Other disposition | −2,483 | $11.86 | $29K | 279,712 |
| 2023-09-28 | MANCHESTER KEITH S Director | Sale | −2,285,783 | $11.55 | $26.4M | 25,724,561 |
| 2023-09-28 | MANCHESTER KEITH S Director | Sale | −3,059,368 | $11.55 | $35.3M | 34,430,591 |
| 2023-09-28 | MANCHESTER KEITH S Director | Sale | −1,104,599 | $11.55 | $12.8M | 12,431,330 |
| 2023-09-28 | MANCHESTER KEITH S Director | Sale | −446,394 | $11.55 | $5.2M | 5,023,787 |
| 2023-09-28 | SVF Investments (UK) Ltd 10% owner | Sale | −10,000,000 | $12.60 | $126.0M | 73,031,667 |
| 2023-09-28 | QVT Financial LP 10% owner | Sale | −8,957 | $11.55 | $103K | 100,804 |
| 2023-09-28 | QVT Financial LP 10% owner | Sale | −2,285,783 | $11.55 | $26.4M | 25,724,561 |
| 2023-09-28 | QVT Financial LP 10% owner | Sale | −3,059,368 | $11.55 | $35.3M | 34,430,591 |
| 2023-09-28 | QVT Financial LP 10% owner | Sale | −3,094,899 | $11.55 | $35.7M | 34,830,463 |
| 2023-09-28 | QVT Financial LP 10% owner | Sale | −1,104,599 | $11.55 | $12.8M | 12,431,330 |
Page 36 of 38 · 748 trades